Vancouver, BC., December 21, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) shares the Cannabis Business Times report that President Donald Trump signed the 2018 Farm Bill Thursday afternoon, signaling the official nationwide legalization of industrial hemp—a moment long-awaited by the cannabis industry.

Earlier this year, U.S. Sen. Mitch McConnell inserted language from his Hemp Farming Act of 2018 into the Farm Bill to federally legalize the cultivation and sale of industrial hemp, which is defined as cannabis that contains less than 0.3-percent THC. Congress passed the $867-billion agricultural legislation Dec. 12, effectively removing hemp from the list of controlled substances and allowing states to regulate its production, commerce and research with approval from the USDA.

The Drug Enforcement Administration will no longer be able to interfere with the interstate commerce of hemp products, which will open the doors for banks, merchant services, credit card companies, e-commerce sites and advertising platforms to do business with hemp companies.

The cannabis industry now looks ahead to increased investment, research, cultivation and sales in a hemp market that Brightfield Group estimates will reach $22 billion by 2022.

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that when completed is anticipated to have over 1.8 million square feet of production space. MYM has a conditional agreement on a project in New South Wales, Australia, an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Investor Relations
Brian Tasker
1.403.616.1045
brian.tasker@mym.ca